facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
4/2021
vol. 108
 
Share:
Send email
Share:
abstract:
Case report

Longitudinal melanonychia and distal onycholysis associated with 5-fluorouracil/adriamycin/cyclophosphamide chemotherapy for breast cancer

Marta Żywno
1
,
Agnieszka Terlikowska-Brzósko
2
,
Witold Owczarek
2
,
Cezary Szczylik
3

1.
Department of Oncology, Military Institute of Medicine, Warsaw, Poland
2.
Department of Dermatology, Military Institute of Medicine, Warsaw, Poland
3.
Department of Oncology, European Health Center, Otwock, Poland
Dermatol Rev/Przegl Dermatol 2021, 108, 305-310
DOI: https://doi.org/10.5114/dr.2021.110763
Online publish date: 2021/12/13
View full text Get citation
 
PlumX metrics:
Introduction
Longitudinal melanonychia presents with pigmented longitudinal streaks of the nail plate. It results from an increased activity of melanocytes or melanocytic hyperplasia in the nail matrix or nail bed and is associated with increased melanin deposition in the nail plate. Distal onycholysis is characterized by separation of the distal part of the nail plate from the nail bed.

Objective
To present a case of longitudinal melanonychia and distal onycholysis associated with 5-fluorouracil/adriamycin/cyclophosphamide chemotherapy.

Case report
A 66-year-old woman, who received 5-fluorouracil/adriamycin/cyclophosphamide for breast cancer developed longitudinal melanonychia and distal onycholysis. After discontinuation of chemotherapy, nail changes improved significantly.

Conclusions
Drug-induced longitudinal melanonychia and distal onycholysis are common adverse effects of breast cancer chemotherapy. This case shows that lesions may resolve after discontinuation of therapy.

keywords:

adriamycin, breast cancer, cyclophosphamide, melanonychia, 5-fluorouracil
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Alergologia – kompendium


Indeks osobowy
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.